Department of Biochemistry and Molecular Biology, University of Miami School of Medicine, 1011 NW 15Th Street, Gautier Building, Room 528, Miami, FL, 33136-1019, USA.
Mol Neurobiol. 2023 Nov;60(11):6441-6465. doi: 10.1007/s12035-023-03456-y. Epub 2023 Jul 17.
Brain endothelial extracellular vesicles carrying amyloid beta (EV-Aβ) can be transferred to neural progenitor cells (NPCs) leading to NPC dysfunction. However, the events involved in this EV-mediated Aβ pathology are unclear. EV-proteomics studies identified Serpine-1 (plasminogen activator inhibitor 1, PAI-1) as a major connecting "hub" on several protein-protein interaction maps. Serpine-1 was described as a key player in Aβ pathology and was linked to HIV-1 infection as well. Therefore, the aim of this work was to address the hypothesis that Serpine-1 can be transferred via EVs from brain endothelial cells (HBMEC) to NPCs and contribute to NPC dysfunction. HBMEC concentrated and released Serpine-1 via EVs, the effect that was potentiated by HIV-1 and Aβ. EVs loaded with Serpine-1 were readily taken up by NPCs, and HIV-1 enhanced this event. Interestingly, a highly specific Serpine-1 inhibitor PAI039 increased EV-Aβ transfer to NPCs in the presence of HIV-1. PAI039 also partially blocked mitochondrial network morphology alterations in the recipient NPCs, which developed mainly after HIV + Aβ-EV transfer. PAI039 partly attenuated HIV-EV-mediated decreased synaptic protein levels in NPCs, while increased synaptic protein levels in NPC projections. These findings contribute to a better understanding of the complex mechanisms underlying EV-Serpine-1 related Aβ pathology in the context of HIV infection. They are relevant to HIV-1 associated neurocognitive disorders (HAND) in an effort to elucidate the mechanisms of neuropathology in HIV infection.
脑内皮细胞外囊泡携带淀粉样蛋白 β(EV-Aβ),可转移至神经祖细胞(NPC),导致 NPC 功能障碍。然而,EV 介导的 Aβ 病理学中的相关事件尚不清楚。EV 蛋白质组学研究发现丝氨酸蛋白酶抑制剂 1(纤溶酶原激活物抑制剂 1,PAI-1)是几个蛋白质-蛋白质相互作用图谱的主要连接“枢纽”。丝氨酸蛋白酶抑制剂 1 被描述为 Aβ 病理学中的关键角色,并且与 HIV-1 感染有关。因此,本研究旨在验证以下假设:丝氨酸蛋白酶抑制剂 1 可以通过 EV 从脑内皮细胞(HBMEC)转移到 NPC,并导致 NPC 功能障碍。HBMEC 通过 EV 浓缩和释放丝氨酸蛋白酶抑制剂 1,该效应可被 HIV-1 和 Aβ 增强。负载丝氨酸蛋白酶抑制剂 1 的 EV 很容易被 NPC 摄取,而 HIV-1 增强了这一事件。有趣的是,一种高度特异性的丝氨酸蛋白酶抑制剂 PAI039 在存在 HIV-1 的情况下增加了 EV-Aβ 向 NPC 的转移。PAI039 还部分阻断了接受 NPC 中线粒体网络形态的改变,这些改变主要发生在 HIV+Aβ-EV 转移后。PAI039 部分减弱了 HIV-EV 介导的 NPC 中突触蛋白水平的降低,同时增加了 NPC 突起中的突触蛋白水平。这些发现有助于更好地理解 HIV 感染背景下与 EV-丝氨酸蛋白酶抑制剂 1 相关的 Aβ 病理学的复杂机制。它们与 HIV-1 相关的神经认知障碍(HAND)相关,旨在阐明 HIV 感染中的神经病理学机制。